Gastric cancer, commonly known as stomach cancer, is the fifth most common cancer globally and the fifth leading cause of cancer-related deaths.

Treatment of stomach cancer is multifaceted, involving a combination of surgery, chemotherapy, radiation, targeted therapy, immunotherapy, and supportive care. The choice of treatment depends on ...

At Bricks and Minifigs in East Brainerd there are thousands of Lego pieces and miniature figures like Dolly Parton, Ed ...

Tislelizumab-jsgr (Tevimbra) was approved in combination with chemotherapy for the treatment of unresectable or metastatic ...

Researchers investigated the diagnostic value of assessing serum lipid profiles and insulin resistance markers for gastric cancer.

The Food and Drug Administration (FDA) has approved Tevimbra (tislelizumab-jsgr) in combination with platinum and ...

Tevimbra is already approved in the US for the treatment of unresectable or metastatic oesophageal squamous cell carcinoma ...

Tevimbra is also approved in the U.S. as monotherapy for the treatment of adult patients with unresectable or metastatic esophageal squamous cell carcinoma after prior systemic chemotherapy that doesn ...

Patients on the Tevimbra combo had a 20 percent reduction in risk of death compared to those on chemotherapy alone.

Overall, this fundamental study identified a novel role of NOLC1 in regulating p53 nuclear transcriptional activity and p53-mediated ferroptosis in gastric cancer. The evidence supporting the ...

Leap Therapeutics focuses on developing DKN-01, a promising monoclonal antibody for solid tumors, with encouraging early ...

Discover how ctDNA methylation biomarkers enhance gastric cancer monitoring, providing a non-invasive method for prognosis ...